{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:30:55Z","timestamp":1770971455579,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:p>Pocapavir exhibits antiviral activity against both polio and nonpolio enteroviruses. There is limited experience of the use of this investigational drug in young children with enteroviral infection. We describe the successful clearance of prolonged immunodeficiency-associated vaccine-derived type 3 poliovirus infection by pocapavir in an infant with underlying X-linked agammaglobulinemia.<\/jats:p>","DOI":"10.1097\/inf.0000000000002584","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T07:56:59Z","timestamp":1583740619000},"page":"435-437","source":"Crossref","is-referenced-by-count":23,"title":["Clearance of Immunodeficiency-associated Vaccine-derived Poliovirus Infection With Pocapavir"],"prefix":"10.1097","volume":"39","author":[{"given":"Julie","family":"Copelyn","sequence":"first","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Red Cross War Memorial Children\u2019s Hospital"},{"name":"the Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Hincks","sequence":"additional","affiliation":[{"name":"ViroDefense, Inc., Chevy Chase, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo M.","family":"Wilmshurst","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology, Neuroscience Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonita","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health, Red Cross War Memorial Children\u2019s Hospital, University of Cape Town, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Howard","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabelle","family":"Jallow","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelina","family":"Moonsamy","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lerato","family":"Seakamela","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Suchard","sequence":"additional","affiliation":[{"name":"Centre for Vaccines and Immunology, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa"},{"name":"Chemical pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc S.","family":"Collett","sequence":"additional","affiliation":[{"name":"ViroDefense, Inc., Chevy Chase, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Eley","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases Unit, Red Cross War Memorial Children\u2019s Hospital"},{"name":"the Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/cid\/ciz361","article-title":"Accelerated immunodeficiency-associated vaccine-derived poliovirus serotype 3 sequence evolution rate in an 11-week-old boy with X-linked agammaglobulinemia and perinatal human immunodeficiency virus exposure.","volume":"70","author":"Jallow","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fimmu.2017.01103","article-title":"Prolonged excretion of poliovirus among individuals with primary immunodeficiency disorder: an analysis of the world health organization registry.","volume":"8","author":"Macklin","year":"2017","journal-title":"Front Immunol"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.vaccine.2018.02.059","article-title":"New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.","volume":"36","author":"Shaghaghi","year":"2018","journal-title":"Vaccine"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/AAC.00671-09","article-title":"In vitro antiviral activity of V-073 against polioviruses.","volume":"53","author":"Oberste","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20230912","first-page":"335","article-title":"Antiviral activity of pocapavir in a randomized, blinded, placebo-controlled human oral poliovirus vaccine challenge model.","volume":"215","author":"Collett","year":"2017","journal-title":"J Infect Dis"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.1128\/AAC.00539-12","article-title":"Characterization of poliovirus variants selected for resistance to the antiviral compound V-073.","volume":"56","author":"Liu","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/INF.0000000000000497","article-title":"First use of investigational antiviral drug pocapavir (v-073) for treating neonatal enteroviral sepsis.","volume":"34","author":"Torres-Torres","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20230912","first-page":"2324709617729393","article-title":"Neonatal enterovirus myocarditis with severe dystrophic calcification: novel treatment with pocapavir.","volume":"5","author":"Wittekind","year":"2017","journal-title":"J Investig Med High Impact Case Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:56:16Z","timestamp":1694559376000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002584","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}